"Each treatment phase lasts 4-6 weeks during which 0.05 ml human embryonic stem cells is injected. The physician continuously administers the HESC. No immune-suppressants are given to the patients. In addition to HESC therapy, the patient receives physiotherapy and occupational therapy," said Geeta Shroff, stem cells specialist at Delhi-based Nutech Mediworld Hospital.